ESMO Congress 2026Developing

HRS-4642

3 reports2 sourcesupdated 8 hours ago

Start here

No synthesis yet — start with the coverage timeline below.

Coverage timeline

Follow the coverage to see the different angles.

Oct 26

22:07
x.com
Upper GI #RapidOral session at @myESMO #ESMO26
20:00
clinicaltrials.gov
Effect of Itraconazole on the Pharmacokinetics of Intravenous HRS-4642 in Healthy Participants

Oct 25

21:46
x.com
KRASi is moving into neoadjuvant treatment of pancreatic cancer and showed promising results in different combinations: #ESMO26 KRAS G12Di inhibitor HRS-4642 combined with chemo, I

Heat trend for this story

Heat now 19·Peak in the comparable set 24 (Oct 26 23:00)·Change over 24h in the comparable set +146%·Participants now 3

Participants counted3

Heat over time

Participants counted above, heat below. The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's reading; the left and right arrow keys work too.